7 Biotech Stocks With Catalysts Beyond COVID
Covid-19 vaccines aren’t the only ones you should be paying attention to” – and they highlight seven “second-tier” biotechs with catalysts beyond COVID-19 vaccines that may be worth considering.
Covid-19 vaccines aren’t the only ones you should be paying attention to” – and they highlight seven “second-tier” biotechs with catalysts beyond COVID-19 vaccines that may be worth considering.
The recent pullback in biotech “offers a chance to get into exciting areas of biotech research like gene editing and oncology at better prices.”
Two clinical-stage biotech stocks with the potential to deliver gains of 100% or more.
What makes the genetic testing and sequencing company featured in today’s article potentially the best coronavirus stock investors can buy right now?
As a result of rising demand, artificial intelligence, increasing partnerships and scientific breakthroughs, Deloitte declared in a January report that the life sciences industry, including biotechnology, will be “stronger than ever” in 2021.
The company featured in today’s article finds itself at the intersection of biotech and cannabis – an intersection that could be worth $50 billion by 2029.
New Biotech World Order – surging share prices and booming initial public offerings of biotech stocks.
What are the most affordable biopharmaceutical growth stocks in the S&P 500 right now? Or, as today’s article puts it, which biopharma stocks in the… Read More »“The Most Growth, At The Cheapest Price”
Why might the stock highlighted in today’s article – shares of which have more than tripled investors’ money over the past year – be the… Read More »3 Reasons This Could Be “The Best Biotech Stock You Can Buy At The Moment”
When it comes to the five biotech penny stocks to watch this quarter highlighted in today’s article, the author emphasizes that “These aren’t just names… Read More »There’s Good Reason To Watch These 5 Biotech Penny Stocks This Quarter